|
Alan J. Main Ph.D. has been our executive vice president of pharmaceutical research since February 2007 and served as our senior vice president Lexicon Pharmaceuticals from July 2001 to February 2007. Dr. Main was president and chief executive officer of Coelacanth Corporation a leader in using proprietary chemistry technologies to rapidly discover new chemical entities for drug development from January 2000 until our acquisition of Coelacanth in July 2001. Dr. Main was formerly senior vice president U.S. Research at Novartis Pharmaceuticals Corporation where he worked for 20 years before joining Coelacanth. Dr. Main holds a B.S. from the University of Aberdeen Scotland and a Ph.D. in organic chemistry from the University of Liverpool England and completed postdoctoral studies at the Woodward Research Institute. | 